SAB Biotherapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
SAB Biotherapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q3 2019 to Q2 2024.
  • SAB Biotherapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending June 30, 2024 was 10M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 10M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 10M 0 0% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 10M 0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 10M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 10M 0 0% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 10M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 10M 0 0% Dec 31, 2022 10-K 2024-03-29
Q3 2022 10M +9M +900% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 10M +9M +900% Jun 30, 2022 10-K 2023-04-14
Q1 2022 10M +9M +900% Mar 31, 2022 10-K 2023-04-14
Q4 2021 10M 0 0% Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 1M Sep 30, 2021 10-Q 2021-11-22
Q2 2021 1M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 1M Mar 31, 2021 10-Q 2021-05-21
Q4 2020 10M Dec 31, 2020 10-K/A 2023-04-28
Q3 2019 50M Aug 31, 2019 10-K/A 2023-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.